A Landmark Achievement: First CAR T-Cell Therapy Infusion at Our Campus

On 10th April 2026, our institution achieved a remarkable milestone with the successful administration of its first CAR T-Cell Therapy infusion on campus. This groundbreaking advancement marks a new era in the treatment of complex blood cancers, bringing cutting-edge, personalized therapy closer to our patients.

The occasion represents not just a medical achievement, but the culmination of dedicated teamwork, meticulous planning, and an unwavering commitment to excellence in patient care. CAR T-Cell Therapy, known for its transformative potential, offers renewed hope to patients who have limited treatment options.

This milestone stands as a testament to our continuous efforts to bring world-class innovations to our doorstep, ensuring that patients receive the most advanced and compassionate care possible—right here at home.